Alterola Biotech, Inc.
ABTI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7 | $12 | $35 | $40 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $1 | $1 | $1 |
| Enterprise Value | $9 | $13 | $37 | $42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | $0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | $0 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.001 | 0 | -0.001 |
| % Growth | 77.8% | -550% | 128.6% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$1 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$1 |